Author

Qing Liu

Institutions: Macau University of Science and Technology, University of Science and Technology of China, Changsha Medical University

Observed institutions: Macau University of Science and Technology, University of Science and Technology of China, Sun Yat-sen University, Changsha Medical University, University of Macau, Second Affiliated Hospital of Chongqing Medical University, Sinocelltech Group (China), Chongqing Medical University, University of Hong Kong

ORCID: 0000-0002-0773-3843

Observed ORCID: 0000-0002-0773-3843

OpenAlex ID: A5100345184

Spontaneous binding of potential COVID-19 drugs (Camostat and Nafamostat) to human serine protease TMPRSS2

2020 · Haixia Zhu, Wenhao Du, et al. · Computational and Structural Biotechnology Journal · 35

Impaired antibody responses were observed in patients with type 2 diabetes mellitus after receiving the inactivated COVID-19 vaccines

2023 · Feng Xiang, Boyu Long, et al. · Virology Journal · 19

In Silico Study of the Acquired Resistance Caused by the Secondary Mutations of KRAS G12C Protein Using Long Time Molecular Dynamics Simulation and Markov State Model Analysis

2022 · Gao Tu, Qing Liu, et al. · International Journal of Molecular Sciences · 19

Anti–SARS-CoV Immunoglobulin G in Healthcare Workers, Guangzhou, China

2005 · Wei-Qing Chen, Ci-Yong Lu, et al. · Emerging infectious diseases · 18

Upgrade of chrysomycin A as a novel topoisomerase II inhibitor to curb KRAS-mutant lung adenocarcinoma progression

2022 · Junmin Zhang, Pei Liu, et al. · Pharmacological Research · 16

In silico study of intrinsic dynamics of full-length apo-ACE2 and RBD-ACE2 complex

2021 · Qing Liu, Yuwei Wang, et al. · Computational and Structural Biotechnology Journal · 15

Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Monoclonal Antibody (SCTA01) Targeting SARS-CoV-2 in Healthy Adults: a Randomized, Double-Blind, Placebo-Controlled, Phase I Study

2021 · Yinjuan Li, Lu Qi, et al. · Antimicrobial Agents and Chemotherapy · 13

Alisol B 23-acetate broadly inhibits coronavirus through blocking virus entry and suppresses proinflammatory T cells responses for the treatment of COVID-19

2023 · Qiaohui Du, Ronghui Liang, et al. · Journal of Advanced Research · 9

Discovery of the Cryptic Sites of SARS-CoV-2 Papain-like Protease and Analysis of Its Druggability

2022 · Yue Qiu, Qing Liu, et al. · International Journal of Molecular Sciences · 6

Salvianolic Acid A From Salvia miltiorrhiza Suppresses Endometrial Carcinoma Progression via CD40 ‐ AKT ‐ NF ‐ κB Pathway

2025 · Chunhua Zhang, Qing Liu, et al. · Scandinavian Journal of Immunology · 3

MPBuild: An Automated Pipeline for High-Fidelity Membrane Protein Simulation System Construction

2025 · Qing Liu, Wei Ding, et al. · Journal of Chemical Theory and Computation · 1

A Biweekly GLP ‐ 1R Agonist Designed With Drug‐Free Intervals for Enhanced Efficacy, Receptor Homeostasis and Gastrointestinal Tolerability

2026 · Wei Ding, Qing Liu, et al. · Diabetes Obesity and Metabolism

Mapping the Intersection of Traditional Chinese Medicine and Ultrasound Therapies in Tumor Microenvironment Research (2014–2024): A Knowledge Atlas Study

2026 · Ruiyi Jing, Yuxi Nie, et al. · Cancer Biotherapy and Radiopharmaceuticals

Research progress on the mechanism of action of Salvia miltiorrhiza and its components in the treatment of endometrial carcinoma

2024 · Chunhua Zhang, Qing Liu, et al. · Cellular and Molecular Biology

Long-Timescale Simulations Revealed Critical Non-Conserved Residues of Phosphodiesterases Affecting Selectivity of BAY60-7550

2022 · Qing Liu, Menghua Song, et al. · Computational and Structural Biotechnology Journal

Spontaneous Binding of Potential COVID-19 Drugs to Human Serine Protease TMPRSS2

2020 · Haixia Zhu, Wenhao Du, et al. · ChemRxiv

Works count: 16

Citation count: 154

H-index: 8

I10-index: 7